Resources

Why Australia should be your choice for CGT development

The development of cell and gene therapy is rapidly growing in our industry with a…

Cell TherapiesFebruary 22, 2023

News

Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia

Cell Therapies Pty Ltd (CTPL) has been engaged by Germany-based biopharmaceutical company BioNTech SE (BioNTech)…

Cell TherapiesSeptember 21, 2022

News

Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group

We are delighted to be part of the Steering Group to lead Australia’s Cell and…

Cell TherapiesAugust 3, 2022

News

Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients

Cell Therapies is partnering with Carina Biotech, a leading Australian immuno-oncology company, to manufacture their…

Cell TherapiesMay 31, 2022

News

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

Professor James Angus has been appointed the new Lieutenant-Governor of Victoria by Her Excellency the…

Cell TherapiesNovember 15, 2021

News

RM Catalyst consortium reports reveal Australia’s potential

The RM Catalyst consortium recently published two reports revealing Australia's potential to become a global…

Cell TherapiesNovember 11, 2021

News

Announcement from the Chair of the Cell Therapies Board

The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle…

Cell TherapiesOctober 13, 2021

News

Protecting your cell therapy trial by building resilience in your supply chain

Supply chain complexity has always been a factor in healthcare. Drugs are often time- or…

Cell TherapiesSeptember 7, 2021

News

The fast path to first-in-human cell therapy trials

The development of cell and gene therapies (CGT) holds enormous promise for treating many different…

Cell TherapiesSeptember 6, 2021

News

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesJune 21, 2021

News

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 30, 2021

News

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 6, 2021

Filter

Cell Therapies Supports Commencement of Australian Phase I/Ib Clinical Trial of A-SEEDS’ ACS2015 CAR-T Therapy for Solid Tumours

Translating innovative cell therapies: What is GMP?

Cell Therapies and Skin2Neuron Announce Manufacturing Agreement to Advance First in Human Neurorestorative Cell Therapy

News and Resources

The latest news and insights from Cell Therapies

Why Australia should be your choice for CGT development

Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia

Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group

Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

RM Catalyst consortium reports reveal Australia’s potential

Announcement from the Chair of the Cell Therapies Board

Protecting your cell therapy trial by building resilience in your supply chain

The fast path to first-in-human cell therapy trials

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate